BEXIMCO (AUBEX PHARMA Pty Ltd)
Product name
BEXIMCO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
162 (255 working days)
Active ingredients
Azelastine hydrochloride, fluticasone propionate
Registration type
New generic medicine
Indication
Symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine